The applicant asserted that the Axoguard HA+ Nerve Protector TM demonstrates clinical improvement in: (1) nerve health in an injured tissue bed through less adhesion, extraneural scarring, and inflammatory markers, (2) nerve health in an injured tissue bed through decreased friction between the nerve and surrounding tissue to allow for gliding and to minimize potential for soft tissue attachment, (3) device performance due to its sodium hyaluronate and sodium alginate gel layer that allows for nerve gliding, and (4) sensory and motor symptoms
Halo nevi have the dermoscopic features of benign MNs, with globular and/or homogeneous patterns that are typically observed in children and young adults
Katie's been injecting GHK-Cu, a copper peptide, for several weeks now and she's confident it's making a difference to her skin
Rorth R, Jhund PS, Mogensen UM, Kristensen SL, Petrie MC, Kober L, McMurray JJV
However, if the baseline risk is extremely low, the absolute increase may be very small
Questions to Ask Your Doctor Am I a good candidate